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Abstract  
Background Understanding consumer perceptions is crucial if effective food safety policy and risk 
communication are to be developed and implemented. We sought to understand how those 
living with food allergy assess risk with precautionary allergen labelling (PAL) and their preference 
in how risks are communicated within a Quantitative Risk Assessment (QRA) framework.  
 
Methods The Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM) 
labelling online survey was developed for adults and parents of children with food allergy and 
distributed across Germany, Ireland, Netherlands, Spain and UK via patient support groups.  
 
Results There were 1560 complete responses. ‘This product is not suitable for’ was selected as first 
choice for PAL by 46% overall and ‘May contain’ was selected as the first choice by 44%. Seventy-
three percent reported that it would improve their trust in a product if a QRA process had been 
used to make a decision about whether to include ‘may contain’. Overall 66% reported that a 
‘statement + symbol’ on the label indicating a QRA, would help them to understand the risk 
assessment process that had been used by the food manufacturer. 
 
Conclusions Consumers want to know what process has actually taken place for the placing of a 
PAL and/or risk assessment statement on a particular food product. Our findings provide a basis 
for the development of more informative communication around food allergen risk and safety 
and support evidence-based policy-making in the context of the legislative requirements of the 
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Introduction  
Food allergy (FA) is a major public health concern affecting an estimated 20 million Europeans 
with high costs to public health services (1-4).  A systematic review and meta-analysis has 
reported the pooled lifetime prevalence of self-reported FA as 17.3% (95% CI: 17.0-17.6)(2). 
Avoidance of the trigger food(s) is central to effective self-management but unintentional 
consumption is common causing frequent reactions, some of which may be life-threatening (5-7). 
Admission rates for anaphylaxis have increased approximately three-fold between 2005 and 2012 
(8-10). Health related quality of life (HRQL) studies have shown a strong adverse impact of FA on 
HRQL across the life-course (11-13).  
 
Uncertainty and ambiguity have been shown to be central themes in living with food allergy, 
leading to anxiety and avoidance on the one hand and/or frustration and risky behaviours on the 
other (11, 13-17). Even though there has been a proliferation of precautionary allergen labels 
(PAL)(18), the current use (or non-use) of PAL is not clear due to lack of consensus on when and 
how to apply it. Therefore, consumers with food allergies have no reference to what PAL or its 
absence actually means. Of particular concern is the issue of communicating the risk due to the 
presence of specific allergens in a particular food product. The European Union’s Food 
Information for Consumers (and other relevant food and health and safety legislation) defines a 
list of 14 foods as priority allergens (cereals containing gluten, crustaceans, eggs, fish, peanuts, 
soybeans, milk (including lactose), nuts, celery (including celeriac), mustard, sesame, sulphur 
dioxide/sulphites, lupin, molluscs); their use as ingredients or processing aids in food and drink 
must be declared on the label or made available to the consumer so as to make safe, informed 
food choices (19). For unintended allergen presence (UAP), primarily through manufacturing 
cross-contact, the situation is different. There are no well-defined, consistent rules governing these 
situations (20). This has caused confusion and uncertainty among food regulators, food industry 
and, most importantly consumers with FA about the meaning of PAL statements.  Statements are 
mistakenly viewed by consumers and health care providers as conveying different levels of risk, 
which research has shown is not the case (21). Risk is therefore increased for the consumer while 
confidence and food choice is reduced. A harmonized approach is urgently needed. 
 
Risk assessment is the evaluation of known or potential hazards of food production (22, 23,24). 
Current food industry approaches to safety risk assessment in relation to application of PAL lack 
transparency and consistency, with approaches ranging from non-existent to sophisticated, and 
no consensus on easy-to-use and generally applied risk tools for food allergens in Europe. A 
quantitative risk assessment (QRA) approach is being developed to ensure that only products 
likely to cause a reaction have a PAL statement. QRA aims to provide a harmonised and 
standardised approach to determine whether the allergen is likely to be unintentionally present in 
a product and is above a certain agreed threshold or level of risk with regard to UAP (23,25-26). 
The “threshold” (reference dose) for labelling is an amount below which only a defined proportion 
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(23). Manufacturers would be required to assess the amount of each unintentionally present 
allergen in their product. If any of these could cause a reaction in at least one in 100 allergic 
consumers, a PAL statement would be applied.  Ideally this would be mandatory, since this would 
be the most efficient and helpful approach for all stakeholders. For consumers, this would mean 
more certainty, and perhaps even more food choice, for HCPs this would mean a better basis for 
advice, and clear guidelines for industry, and for regulators with regard to enforcement. 
 
Previous work in this area has shown that consumers take into account many factors when 
evaluating a food hazard including allergens, beyond technical risk assessments (19-22). 
Integrated approaches to food allergen and allergy management (iFAAM) is an EU-funded 
project,  one aim of which is  to improve the management of food allergens by the food industry 
for the benefit of consumers, especially those with FA (28), thereby minimising the public health 
burden of allergic reactions to foods. The iFAAM labelling survey was developed for adults and 
parents of children of all ages with FA and distributed across five European countries. The survey 
related specifically to pre-packed manufactured products. Our aim was to understand how 
consumers living with FA assess risk when making decisions based on PAL. Our approach focused 
on assessing consumers’ preference in how the risk of UAP was communicated on the food label 
within the context of a QRA framework across Europe. The outcomes from this research should 
help to guide on issues of acceptability and provide a basis for the development of more 
informative communication around food risk and safety.   
 
Methods  
We used a cross-sectional design with convenience sampling. An online survey was developed by 
iFAAM in 2017.  Ethical approval was given by the National University of Ireland, Cork, Ireland. 
Patient support group leaders, clinicians and a psychologist were involved in an iterative process 
of questionnaire development.  Six consecutive drafts were developed with the final draft subject 
to testing by a representative pilot group of respondent types (N=12). Modifications were made 
following feedback. The questionnaire was translated by a native speaker into German, Dutch and 
Spanish; these documents were then back translated by another person into English to ensure fact 
and content validity. The questionnaire can be found in the online supplement. The online survey 
link and information on the project was placed on the website of patient support groups in 2017 
involved in the iFAAM project in Germany, Ireland, Netherlands, Spain and UK Since it is not 
possible to distinguish between active and non-active users of these websites, calculation of 
response rate relative to number of registered users would have poor validity. There were three 
eligible respondent types: adults with FA; parents of children with FA; and adults with an FA who 
also have a child with FA.. The online link remained open for six weeks.  
 
The survey consisted of 16 questions (with 2 additional open questions) divided into 5 main 
sections (Figure S1 and online repository).  Following basic demographic and clinical questions, 
respondents were asked when they read a PAL statement, how confident they were that PAL 
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Respondents chose among alternatives in phrasing and symbols that would make it easier for 
them to identify foods that may contain an allergen due to cross-contamination. Three examples 
using milk and egg were given, alongside phrases which could be ranked in order of preference. 
Respondents also ranked their preference for a single statement or a statement that distinguished 
between the type and frequency of allergen presence (e.g. ‘=used if the allergen is only likely to 
be found in some packets of the product’; ‘=used if allergen is likely to be unavoidably present in 
all packets of the products’).   
 
Two statements ‘This product has undergone a risk assessment and found to be safe to consume’; 
and ‘This product has undergone a risk assessment and there is risk of an allergic reaction (i.e. not 
safe to consume)’, were rated from 1 (not at all helpful) to 5 (very helpful).  Next, a combination of 
statements/information that may appear on a food label could be rated on the same scale. 
 
At present the use of PAL is voluntary. To elicit responses to a hypothetical situation, participants 
were asked that if QRA was mandatory, how true (1=not at all true to 5=very true) the following 8 
factors would be: easier to understand; able to buy more products; shopping would be much 
quicker; be more scientific; less anxious when buying a food product; make me safer when I eat a 
food product; make me safer when I buy a food product, and fewer products with PAL. Finally, we 
asked respondents 1) how well QRA has been explained to date and 2) to rank their preference 
(on a scale of 1 to 6, with 1 being first choice) on who should explain quantitative risk assessment 
to consumers with food allergies.     
 
Statistical analysis 
All data underwent preliminary tests for normality and met the requirements for the statistical tests 
selected, outlined below (28). Cases with missing data >20% were excluded (28). Residual and 
scatter plots examining assumptions of normality, linearity, and homoscedasticity met the relevant 
criteria (29).  A series of Univariate Analyses of Variance (F test), and where appropriate Chi 
Square test (χ2 test) for Independence (Pearson’s Chi Square, Fisher’s Exact Test), were conducted 
to assess associations for country and participant type with regard to (1) demographic, (2) clinical 
and (3) all responses to questions on PAL (Figure S1). Multivariate Analyses of Variance (F test) 
were conducted when appropriate to control for the effects of all independent variables on 
dependent variables simultaneously. Finally, a Hierarchical Multiple regression was used to assess 
the association between feeling/attitude variables on QRA and ‘trust in a product if a quantitative 
risk assessment (QRA) had been carried out’. 
 
Results  
There were a total of 1582 responses. Of these, 64 respondents completed the questionnaire 
twice (because there was more than one person in their household with FA). Data from these 
respondents (N=64) were counted only once since there were no significant differences (p >0.1 to 
0.9 for all variables) between first and second responses for these 64 cases.  Data was missing for 
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Table 2 shows the profile of the participants. There were 535 (34%) adults with FA, with a mean 
age of 44.0 years (range 18-82). The overwhelming majority of the cases were diagnosed formally, 
with only 2% of the entire data set ‘self-diagnosed’ or diagnosed by someone other than by a 
health professional (e.g. by an alternative practitioner).  Over half of responses (N=907; 58%) were 
from parents (86% Mothers) who had one or more children diagnosed with FA. The final 8% were 
composed of parents of a child with FA, who themselves had FA.  These were placed with the 
‘parent group’ for analysis purposes. The mean age for the first child/only child with FA was 9.4 
years (range 1-35) and 61% were male. Overall, 65% reported that they or their child had 
experienced a severe reaction to a food, and they reported an average of three allergies. 
Adrenaline auto-injector prescriptions were most frequent among participants from UK and 
Ireland (95%) and Spain (83%) 
 
Attitudes and feelings towards precautionary allergen labelling (PAL)  
When asked whether a product that has no PAL is safe to eat, 18% answered ‘yes’, 22% replied 
‘no’, 51% ‘not necessarily’, and 9% were ‘unsure’. Table 3 shows the reasons participants gave for 
reading PAL. There were no associations for parents or adults on any of the reasons given except 
that parents (68%) were more likely than adults (55%) to check the label every time that a product 
is purchased [χ2= 33.2, p=0.0001] On confidence that PAL helps avoid allergic reactions, the 
mean score was 2.8 (SD 1.4) which equates to “Hardly confident”.  Analysis of variance found no 
significant main effect differences across countries [F=2.5, p=0.1, η 2 =0.005] or a significant 
interaction with participant types [F=.0.5, p=0.8, η 2 =0.002].  
 
Preference for labelling phrases and symbols 
The survey included preferences for 3 statement formats that identify foods that may contain an 
allergen due to cross-contamination. ‘This product is not suitable for consumers with xy allergy’ 
was selected as first choice by 46% overall, ‘May contain xy (allergen)’ was selected as the first 
choice by 44%., and ‘Accidental presence of xy (allergen)’ was least popular at 7%, with 3% 
choosing ‘other’ option. A significant association was found between country and phrase type 
(x²=28.3, p=0.001). ‘This product is not suitable for’ was ranked first by a higher proportion of 
respondents from the UK and Ireland (56%), and Germany (48%). ‘May contain’ was the first 
choice for Netherlands (44%) and Spain had the highest proportion of those who ranked 
‘Accidental presence’ as first choice (11%). ‘This product is not suitable for’ was ranked first by a 
similar proportion of respondents of adults (49%) and parents (47%). A single statement was 
preferred by 68% of the sample compared to a statement that distinguishes between the type and 
frequency of allergen presence with no significant association for country [χ2= 1.2, p=0.7].  or 
participant type [χ2= 0.25, p=0.7],  
 
Participants were asked how helpful a series of statements would be when choosing a product. 
‘This product has undergone a risk assessment and there is risk of an allergic reaction (i.e. not safe 
to consume)’ was seen as ‘very helpful’ by a slightly higher proportion (52%) than the statement 
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was one country difference – UK/Ireland reported ‘safe to consume’ as ‘very helpful’ in a higher 
proportion than ‘unsafe to consume’ (63% vs 54%), although chi-square test was not significant. 
Finally, participants rated four options (Table 4) in terms of how helpful they would be when 
choosing a product.  The proportion of those who endorsed each option as ‘quite a bit’ or ‘very’ 
helpful increased as information became more complex.  Option 4 was the most popular with 
66% reporting that the statement would be ‘quite a bit’ or ‘very’ helpful.  Number of allergies 
reported and past severe reaction did not have an impact. Significantassociations were found for 
country[χ2= 26.9, p=0.02] (Table 4). The Netherlands had a higher percentage endorsing option 
3 (65%) compared to option 4 (53%) and Germany endorsed both option 3 and 4 equally. 
 
Attitudes to quantitative risk assessment and to placing a label on a product. 
Seventy three percent reported that it would improve their trust in a product  if a QRA process 
had been used to make a decision about whether to include “may contain”. Only 9% reported that 
it would slightly or considerably reduce their trust. Thirty two percent of adults and 44% of parents 
whose child had a past severe reaction stated that QRA would ‘considerably improve their trust’. 
There were no significant differences between countries (p>0.05).  
 
Participants were asked about how true a series of statements would be (Table 5) if risk 
assessment was mandatory. Overall, 53% of participants answered ‘quite a bit true’ or ‘very true’ 
for all statements on mandatory QRA for food products (Table 5).  The statements with the 
highest agreement were ‘easier to understand’ (Mean 3.6, SD 1.2); ‘fewer products with ‘may 
contain’ (3.5, 1.2); ‘trust in the product would increase (3.5, 1.3); and ‘make me less anxious when 
buying a food product’ (3.4, 1.3).  Multivariate analysis showed a significant main effect difference 
across countries for all statements [F=5.9, p =0.01, η 2 =0.02], however  there was no significant 
interaction between participant type and country for any of the statements [F=0.77, p=0.9, η 
2=0.008].  
 
Next the association between feeling/attitude variables on mandatory QRA and agreement with 
the statement ‘My trust in a food product would increase’ was assessed.  All the feelings and 
attitudes to QRA (easier to understand; able to buy more products; shopping would be much 
quicker; be more scientific; less anxious when buying a food product; make me safer when I eat a 
food product; make me safer when I buy a food product, and fewer products with “may contain”) 
were significantly and positively associated with trust in the food product (Table 6). Together they 
explained 77% of the variance. The item ‘Make me safer when I eat a food product’ was most 
closely associated with trust followed by ‘able to buy more food products’, ‘shopping would be 
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Communicating information on quantitative risk assessment 
Thirty six percent of the participants in this study agreed as ‘true’ or ‘very true’ that QRA was not 
explained properly to date. To assess preference with regard to communication on QRA, 
participants were asked to rank their preference (on a scale of 1 to 6, with 1 being first choice) on 
‘Who do you think should explain quantitative risk assessment to consumers with food allergies?’   
 
Overall, physicians/allergists were the most popular first choice for information on QRA (39%), 
together with regulators/government (39%).  This was followed by food manufacturers (36%) and 
Patient support groups (29%). First choice varied according to country (Table S1), however there 
no significant associations according to participant type, or gender (p>0.05). Participants ranked 
their preference on ‘Where do you think consumers with food allergy should get information 
about quantitative risk assessment?’ Information in shops/supermarkets was the most popular first 
choice (50%), followed by doctor’s surgery (20%), smart phone (14%), traditional media (14%) and 
social media (12%). Chi-square analysis showed no significant associations according to 
participant type, gender or country (p>0.05). 
 
Discussion  
Many respondents were not confident about the reliability and trustworthiness of PAL, as shown in 
previous research. The value of PAL has been devalued through overuse and inconsistent 
application; it can act as a barrier to informed decision making and increases risk to consumers 
with FA (19,30-32). Participants were also unsure whether a product is safe to eat if it has no PAL 
indicating uncertainty, a central theme in food allergy that has a negative impact on quality of life 
(10) (Figure S2). There is uncertainty also among food businesses about what is required by 
regulators, which drives the use of criteria other than the actual health risk (e.g. business risk).  
 
Prior to this study, little information about consumers’ preference for information/statements 
about risk assessments on labels was available. Zurzola and colleagues completed a study in 2017 
(ref ) where they presented a symbol “may be present” to represent a LOW level of cross 
contamination to 497 children (59% with food allergy) attending at the Royal Children’s Hospital, 
Melbourne.  Their findings showed that the majority of respondents would find this very useful, 
and the authors emphasise that appropriate education should be provided.  Our study focussed 
on adult/parent consumers and offered multiple preference options. An important part of this 
study was to determine which of several alternatives in phrasing and symbols consumers felt 
would make it easier to identify foods that may contain an allergen due to cross-contamination.  
Overall, consumers strongly welcomed seeing a label that stated clearly that a product had 
undergone a risk assessment, reporting that it would be both useful and helpful. Furthermore, 
32% adults and 44% parents stated that mandatory use would ‘considerably improve their trust’. 
The statement ‘This product has undergone a risk assessment and there is risk of an allergic 
reaction (i.e. not safe to consume)’ was seen as more helpful by a slightly higher proportion (52%) 
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 We found very little variation across countries or participant types on this preference. As long as 
the use of PAL is voluntary, consumers with food allergy want and need to know the background 
for the application or the omission of a PAL statement on a particular food product. With the 
currently not regulated mandatory framework, there was agreement on preference for a 
combination of unintended allergen presence statement, risk assessment statement, and risk 
assessment symbol. Although all four options (with increasing levels of information) were rated as 
helpful by participants, level of helpfulness increased with the complexity of statements.  It is likely 
that food industry may not favour more complex types of labelling but the underlying message is 
that more directive informationwould help consumers to make more informed decisions when 
purchasing food products and would therefore protect them better.  Therefore, to avoid overly 
‘wordy’ additions to products, information in the form of one symbol with a corresponding one or 
two word safety statement, would likely also suffice.  Previous research has shown that the use of 
symbols and a safety statement were the most important food allergen-labelling attributes (32-
33-35-37). 
 
The preference among our participants for more complex information on packaging may seem 
surprising, however advisory labels are helpful if they provide reliable and meaningful information 
on the allergen risk. This information may be augmented by medical data from oral food 
challenges in patients. Complexity without ‘meaningfulness’ increases both uncertainty and 
ambiguity. Furthermore, as current PAL use cannot be associated with any defined level of risk, 
both uncertainty and ambiguity are amplified. When consumers are provided with directive 
information about either the degree of risk or benefit, alongside information on risk management 
practices, judgments of benefit are increased, and perceptions of risk reduced (17,19). A recent 
study in Canada found that the QRA would statement ‘does not contain’ was preferred to the 
statement ‘may contain’ (33).  Many food companies would be reluctant to state ‘does not 
contain’ because it implies zero. This contention underlines the importance of a mandatory 
approach. If all have to apply the system, the meaning is not ‘zero allergen’ but instead that 
‘consumption is unlikely to result in more than a mild allergic reaction when consuming the 
product’. We must also acknowledge issues of level playing field in a competitive environment, 
suggesting that a regulatory approach would probably be most effective. 
 
Trust as a concept has been extensively studied in relation to consumer perceptions of food 
safety, and food risk management in general. Consumer trust in different actors and institutions 
responsible for guaranteeing and controlling food safety, as well as trust in the information 
provided by different information sources that communicate about food safety or food-related 
risks, is considered to be important for consumer confidence in the safety of food (38-40). To 
assess the association feeling/attitude variables on quantitative assessment and ‘trust in a product 
if a quantitative risk assessment (QRA) had been carried out’, we carried out a hierarchical multiple 
regression analysis. Our findings showed that perception of safety, anxiety, convenience, choice 
and understanding would be positively impacted when making purchasing decisions. This finding 
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consumers the process that has actually taken place to lead to the placing of a label on a 
particular food product. 
 
Overall, physicians/allergists were the most popular first choice for information on QRA. The 
information could be given at diagnosis and patients/parents could be directed to further 
supporting information provided online and via phone by patient support groups and others.   
 
This study has limitations, which means the results must be interpreted with caution. This was a 
cross-sectional self-report study with no random sampling frame, an unclear response rate, and 
respondents may not have confirmed FA. Convenience sampling was used because it has 
advantages, the most important being that it is cost-effective and speedy. However, our findings 
may not be generalizable to the target population because of the potential bias inherent in our 
sampling technique, and the respondents are a biased sub-population of patient support group 
members. Therefore, inferences based on our findings should be made only about the sample 
itself. However, we did obtain a large sample which allowed us to examine subgroup differences 
which minimised bias to some extent.  
 
This is the first quantitative study to examine parents of consumers and consumers’ preference for 
risk assessments on labels. Results show that consumers want to know the process that has led to 
a decision to place a label (or not) on a food product. Ensuring an acceptable level of risk for most 
consumers with food allergy presents challenges. However, it is important to remember that 
consumer acceptance is an evolutionary rather than a revolutionary process. Lack of awareness, 
knowledge and familiarity often lead to a sense of dread (triggering more emotional and negative 
responses). In contrast, less mystery yields less fear, which yields more trust and better quality of 
life (41).  
 
The outcomes from this research should help to guide stakeholders when considering issues of 
acceptability of risk by outlining the potential positive impact on a wide array of factors of clearly 
communicating to consumers the process that has actually taken place leading to the placing of a 
label on a particular food product. In the context of acceptability, including them as 
partners/interested parties in determining what is acceptable is critical. The PAL approach coupled 
to QRA does NOT include declaration of the extent to which the allergen may be present – only 
that it is above the ED01 – ED05. Consumers may not understand that allergens are not always 
uniformly distributed so one product may have no detectable peanut but another package of the 
same product could have a whole peanut. Further research is needed on how to convey this 
aspect, for example a different kind of statement may be needed for large amounts that may 
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Percentage of Total 
Sample 
Number of Missing 
Responses  
  Ireland & UK 496 31.4% 5
Germany 673 42.5% 14
Spain 225 14.2% 0
Netherlands 182 11.5% 3
Total 1582 100% 22
 Total (missing responses) 1560 97.2% -
*N=64 completed the questionnaire more than once because they had more than one person with food 
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Table 2. Profile* of the participants from the UK & Ireland, Germany, Spain and Netherlands who took part 
in the study (N=1582). 
Country UK & Ireland Germany Spain Netherlands Total  
 N (%) N (%) N (%) N (%) N (%) 
Parent of 1 or 2 
children with FA ** 
330 (67) 310 (46) 177 (79) 90 (50) 907 (61) 
Adult with FA ** 139 (28) 295 (44) 26 (12) 75 (42) 535 (32) 
Adult & Parent with 
FA 
22 (5) 54 (8) 22 (10) 14 (8) 112 (8) 
Parent/Adult Female 
Gender 
394 (85) 553 (89) 178 (85) 158 (92) 1283 (88) 
Child Female Gender 137 (41) 129 (39) 66 (36) 39 (40) 371 (39) 
Past severe reaction 
(yes) 




456 (95) 361 (56) 181(83) 114 (64) 1112 (298) 
Diagnosed by 
Allergist/Consultant** 
380 (80) 524 (82) 210 (96) 147 (83) 1261 (85) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Child Age ***  12 (8.2) 11 (5.8) 8.5 (5.1) 7 (4.3) 9.6 (5.4) 
Number of Allergies 
*** 
2.8 (1.8) 3.9 (2.7) 3.1 (2.3) 3.9(2.5) 3.4 (2.2) 
 
*There is missing data (<20%) for some cases. FA: food allergy.  
** Significant association for Country p < 0.05 Asymp.Sig. 
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Table 3. The reasons precautionary labelling is read by participants* from UK & Ireland, Germany, Spain, 
and Netherlands (N=1560) 
Country UK & Ireland Germany Spain Netherlands Total 
 N (%) N (%) N (%) N (%) N (%) 
When not familiar ** 187 (38) 219 (33) 26 (12) 58 (32) 490 (30) 
When buying a new 
product ** 
197 (40) 288 (43) 47 (21) 65 (36) 597 (35) 
To check nothing 
has changed ** 
163 (33) 250 (38) 54 (24) 69 (38) 536 (33) 
Every time product 
is bought ** 
288 (59) 434 (66) 178 (82) 109 (60) 1009 (67) 
*Participants could choose one option or as many options as were relevant for them. 
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Table 4. Percentage of participants across 4 countries* who felt each statement type was helpful (N=1560).   
Statement Type UK & 
Ireland 
Germany Spain Netherlands Total 
 N (%) N (%) N (%) N (%) N (%) 
1. Statement for unintended allergen 
presence* 
177 (36) 303 (46) 77 (34) 90 (50) 647 (42) 
2. Statement for unintended allergen 
presence + risk assessment statement 
304 (62) 389 (59) 133 (59) 97 (54) 903 (59) 
3. Statement for unintended allergen 
presence + risk assessment symbol 
290 (59) 422 (64) 137 (61) 116 (65) 965 (62) 
4. Statement for unintended allergen 
presence + risk assessment statement 
+ risk assessment symbol * 
357 (72) 424 (63) 171 (76) 96 (53) 1048 (66) 
*Significant association for Country. χ2= 26.9, p=0.02  
Figures are percentage of participants across 4 countries who selected ‘quite a bit’ (=4) and ‘very much’ (=5) 
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Table 5.  Participants’ feedback on quantitative assessment approach*by country ** (N=1560). 
 UK/Ireland Germany Spain Netherlands 
 M(SD) M(SD) M(SD) M(SD) 
Easier to understand 3.7 (1.2) 3.5 (1.3) 3.8 (1.3) 3.3 (1.2) 
I would be able to buy more products 3.4 (1.4) 3.3 (1.4) 3.6 (1.4) 2.9 (1.4) 
Shopping would be much quicker 3.0 (1.4) 3.0 (1.4) 3.5 (1.4) 2.7 (1.3) 
My trust in a food product would increase 3.5 (1.2) 3.5 (1.3) 3.7 (1.3) 3.1 (1.3) 
Be more scientific  3.7 (1.3) 3.1 (1.3) 3.9 (1.2) 3.1 (1.2) 
Less anxious when buying a food product 3.4 (1.3) 3.4 (1.3) 3.4 (1.4) 3.0 (1.3) 
Make me safer when I eat a food product  3.3 (1.3) 3.3 (1.3) 3.7 (1.3) 3.0 (1.3) 
Fewer products with “may contain” 3.8 (1.3) 3.4 (1.3) 3.6 (1.4) 3.5 (1.2) 
More safe products to choose from 3.6 (1.3) 3.3 (1.2) 3.7 (1.4) 3.2 (1.3) 
*Mean scores and standard deviations for level of agreement for statements on ‘If a quantitative assessment 
was mandatory,how true would the following be for food products?’.Scale of 0= do not agree to 5 = agree 
very much.                                                                                                                                                  
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Table 6: Hierarchical multiple regression* showing the associations between feeling/attitude variables and 














1 Constant 3.1 0.002 0.43 1.70 
Easier to understand 0.09 3.0 0.003 0.03 0.15 
I would be able to buy more products 0.19 5.4 0.000 0.11 0.24 
Shopping would be much quicker 0.13 4.0 <0.001 0.06 0.18 
Be more scientific 0.09 3.3 0.001 0.04 0.15 
Less anxious when buying a food product 0.12 3.0 0.003 0.04 0.19 
Make me safer when I eat a food product 0.28 6.4 <0.001 0.19 0.36 
Fewer products with “may contain” 0.07 3.3 0.001 0.12 0.03 
More safe products to choose from 0.12 3.7 <0.001 0.06 0.19 
Dependent variable :‘My trust in a food product would increase’ (1=not at all to 5 =very much).   
*Controlling for country (UK/Ireland; Germany; Spain; Netherlands), participant type (parent or adult), child 
gender, number of allergens (adult), number of allergens (1-6), severity of  past reactions (yes/no), and 
prescription of auto-injector, entered in Step 1.  
**A standardized beta coefficient compares the strength of the effect of each individual independent 
variable to the dependent variable. The lower and upper bound represent the 95% confidence interval for 
the beta statistic.  
 ***T statistic is the coefficient divided by its standard error.  
 
